Phase II trial of asaley in children with late-stage acute lymphocytic leukemia. 1977

C L Sexauer, and S Morgan, and J van Eys, and D M Komp

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

C L Sexauer, and S Morgan, and J van Eys, and D M Komp
December 1978, Cancer treatment reports,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
March 1976, Cancer treatment reports,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
November 1986, Cancer treatment reports,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
November 1979, Scandinavian journal of haematology,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
October 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
November 1991, Investigational new drugs,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
January 1979, Cancer treatment reports,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
January 1975, Cancer chemotherapy reports,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
August 1991, Investigational new drugs,
C L Sexauer, and S Morgan, and J van Eys, and D M Komp
November 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!